SCRIPTWELLRX Trademark

Trademark Overview

On Wednesday, November 8, 2023, a trademark application was filed for SCRIPTWELLRX with the United States Patent and Trademark Office. The USPTO has given the SCRIPTWELLRX trademark a serial number of 98260094. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, June 17, 2024. This trademark is owned by ScriptWell, Inc.. The SCRIPTWELLRX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Pharmacy Benefit Management Services; PBM services; administration of a program to provide Pharmacy Benefit Management Services; technology services, software solutions, and data analytics for PBM services
scriptwellrx

General Information

Serial Number98260094
Word MarkSCRIPTWELLRX
Filing DateWednesday, November 8, 2023
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkSCRIPT WELL RX
Goods and ServicesPharmacy Benefit Management Services; PBM services; administration of a program to provide Pharmacy Benefit Management Services; technology services, software solutions, and data analytics for PBM services

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, December 6, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameScriptWell, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestwood, MA 02210

Trademark Events

Event DateEvent Description
Saturday, November 11, 2023NEW APPLICATION ENTERED
Wednesday, December 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 17, 2024ASSIGNED TO EXAMINER
Tuesday, June 4, 2024LETTER OF PROTEST EVIDENCE FORWARDED

Related Keywords

scriptwellrx services pharmacy management benefit solutions data analytics software program administration